Akkaraju Srinivas's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Oct 8, 2021
- Accession no.
- 0001209191-21-060060
- Filed
- Oct 8, 2021, 5:09 PM ET
- Trade date
- Oct 6-8, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.97M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akkaraju SrinivasCIK 0001253170 | 10% Owner |
| Samsara BioCapital, L.P.CIK 0001699737 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2021 | Common Stock | PPurchaseAcquired | +61,475 | $13.83 | +$850,199.25 | 7,455,345 | Indirect | |
| Oct 7, 2021 | Common Stock | PPurchaseAcquired | +9,021 | $14.94 | +$134,773.74 | 7,464,366 | Indirect | |
| Oct 8, 2021 | Common Stock | PPurchaseAcquired | +75,000 | $13.12 | +$984,000 | 7,539,366 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.